↓ Skip to main content

Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?

Overview of attention for article published in Alzheimer's Research & Therapy, September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
3 X users
patent
1 patent
facebook
1 Facebook page

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pro: Are we ready to translate Alzheimer's disease modifying therapies to people with Down syndrome?
Published in
Alzheimer's Research & Therapy, September 2014
DOI 10.1186/s13195-014-0060-7
Pubmed ID
Authors

Michael S Rafii

Abstract

Down Syndrome (DS) is caused by trisomy of chromosome 21, which includes the gene for the amyloid precursor protein (APP) and leads to overproduction of beta-amyloid. Clinical-pathological studies indicate that individuals with DS begin demonstrating Alzheimer's disease (AD) pathology during adolescence and that 100% exhibit such changes by age 40. Individuals with DS therefore represent a highly enriched population for AD. Additionally, owing to their baseline intellectual disability, people with DS represent a more vulnerable group of individuals as compared with other populations. Given the recent developments in AD biomarkers, combined with the prospect of achieving greater efficacy with earlier therapeutic intervention, it is logical to include adults with DS in prevention trials for AD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 24%
Student > Bachelor 6 18%
Student > Ph. D. Student 4 12%
Student > Master 3 9%
Other 2 6%
Other 5 15%
Unknown 6 18%
Readers by discipline Count As %
Psychology 5 15%
Medicine and Dentistry 5 15%
Agricultural and Biological Sciences 4 12%
Biochemistry, Genetics and Molecular Biology 4 12%
Neuroscience 2 6%
Other 4 12%
Unknown 10 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 December 2015.
All research outputs
#5,528,450
of 22,908,162 outputs
Outputs from Alzheimer's Research & Therapy
#999
of 1,236 outputs
Outputs of similar age
#55,180
of 243,602 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#4
of 11 outputs
Altmetric has tracked 22,908,162 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,236 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.8. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,602 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.